Little Green Pharma Limited (ASX:LGP) formally completed the implementation of itsMergerwith Cannatrek Ltd on June 1, 2026, marking a structural shift in the Australian and international medicinal cannabis industry. The transaction, executed as a scheme of arrangement under which LGP acquired 100% of Cannatrek's …
Austco Healthcare Limited (ASX:AHC) delivered a trading update for FY26 that would ordinarily be characterized as strongly positive across most financial metrics. The company is forecasting revenue in the range of AUD $90 to $95 million — growth of 11% to 17% on FY25's …
4DMedical Limited (ASX:4DX), a global leader in respiratory imaging technology, delivered one of the more compellingAcquisitionannouncements on the ASX on June 1, 2026. The company's shares rose 4.28% to AUD 4.14 — a meaningful intraday move for a medical technology company — following the …
Paragon Care Limited (ASX:PGC), one of Australia's largest providers of medical equipment, devices, consumables, and pharmaceuticals to healthcare markets across Australia, New Zealand, and Asia, delivered a trading update on June 1, 2026, that combined two distinct positive signals: a material earnings forecast for …
Memphasys Limited (ASX:MEM) delivered one of the most pronounced single-session share price moves on the ASX on June 1, 2026, with shares rising 20% to AUD 0.006 following the announcement of its first South-East Asian commercialisation agreement for the Felix sperm separation system. The …
Chimeric Therapeutics Ltd (ASX:CHM) attracted investor attention on 1 June 2026 after releasing encouraging clinical data from its Phase 1/2 CHM CDH17 trial, which was presented at the American Society of Clinical Oncology (ASCO) meeting in the United States. The update highlighted evidence of …
DorsaVi Limited (ASX:DVL) shares traded higher during the afternoon session on 1 June 2026 after the company announced favourable results from a high-temperature evaluation of its Resistive Random Access Memory (RRAM) technology.
Healthcare technology has become one of the most strategically important areas within global markets, particularly as hospitals and medical systems continue accelerating digital transformation initiatives. Among ASX-listed companies operating in this space, Pro Medicus Ltd (ASX:PME) has consistently attracted investor attention due to its …
Amplia Therapeutics (ASX:ATX) remained on investor radar on 29 May after its shares traded at AUD 0.14, following a 170% rise over the past year. The biotechnology company has attracted market attention as investors continue assessing clinical updates from its ACCENT pancreatic cancer trial …
Acrux Limited (ASX:ACR) has provided additional details regarding its expanded licensing agreement for Lenzetto in Australia, offering further clarity on the timing and structure of milestone payments tied to the product’s planned local rollout. The update follows the company’s announcement that milestone payments under …